KENNEDY KOLLEEN T
Known title: DirectorCIK: 0001531738
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
IPG Photonics to Show High-Energy Laser Systems at Land Forces 2026. IPG Photonics announced it will display its CROSSBOW high-energy laser systems at the Land Forces 2026 event in Perth. This move highlights the company's focus on defense applications, a sector that often carries higher valuations. The stock recently traded down alongside other semiconductor peers, but analysts maintain a wide range of price targets, reflecting mixed views on its future performance.
Transaction History
| ICUI | ▲ Buy | Option Exercise | 1,254 | $0 | 5/13/2026 | View on chart |
| IPGP | ▲ Buy | Grant | 2,436 | $0 | 5/12/2026 | View on chart |
| IPGP | ▲ Buy | Grant | 3,759 | $0 | 5/20/2025 | View on chart |
| ICUI | ▲ Buy | Option Exercise | 1,723 | $0 | 5/13/2025 | View on chart |
| IPGP | ▲ Buy | Grant | 3,022 | $0 | 6/18/2024 | View on chart |
| ICUI | ▲ Buy | Option Exercise | 948 | $0 | 5/15/2024 | View on chart |
| IPGP | ▲ Buy | Grant | 2,296 | $250K | 8/4/2023 | View on chart |
| ICUI | ▲ Buy | Option Exercise | 485 | $0 | 5/17/2023 | View on chart |
| ICUI | ▲ Buy | Option Exercise | 129 | $0 | 5/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
ICU Medical Highlighted in Zacks Industry Outlook
ICU Medical was featured in recent Zacks industry outlooks alongside Neogen and Trulieve, with analysts noting that certain medical product stocks are positioned to benefit from broader industry tailwinds. These mentions suggest continued analyst attention to the company's role in the medical device sector. The stock currently trades with a high trailing P/E of 135.9, while the average analyst target price stands at $193.38.
ICU Medical Highlighted in Zacks Industry Outlook. ICU Medical was featured in recent Zacks industry outlooks alongside Neogen and Trulieve, with analysts noting that certain medical product stocks are positioned to benefit from broader industry tailwinds. These mentions suggest continued analyst attention to the company's role in the medical device sector. The stock currently trades with a high trailing P/E of 135.9, while the average analyst target price stands at $193.38.